Pharmaceutical group ยท Spain
A group of 6 companies with 145 medicines in 7 countries.
6 companies in 4 countries
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Every medicine of every company in the group, current ones first.
1โ25 of 145
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ABFENTIQ 1200 MICROGRAMOS COMPRIMIDOS PARA CHUPAR EFG1,8851 mg ยท Comprimido para chupar | Fentanyl | Spain | Authorised | 2016 |
| ABFENTIQ 1600 MICROGRAMOS COMPRIMIDOS PARA CHUPAR EFG2,5134 mg ยท Comprimido para chupar | Fentanyl | Spain | Authorised | 2016 |
| ABFENTIQ 200 MICROGRAMOS COMPRIMIDOS PARA CHUPAR EFG0,3142 mg ยท Comprimido para chupar | Fentanyl | Spain | Marketed | 2016 |
| ABFENTIQ 400 MICROGRAMOS COMPRIMIDOS PARA CHUPAR EFG0,6284 mg ยท Comprimido para chupar | Fentanyl | Spain | Marketed | 2016 |
| ABFENTIQ 600 MICROGRAMOS COMPRIMIDOS PARA CHUPAR EFG0,9425 mg ยท Comprimido para chupar | Fentanyl | Spain | Marketed | 2016 |
| ABFENTIQ 800 MICROGRAMOS COMPRIMIDOS PARA CHUPAR EFG1,2567 mg ยท Comprimido para chupar | Fentanyl | Spain | Marketed | 2016 |
| ACALKA 1080 mg COMPRIMIDOS DE LIBERACION PROLONGADA1080 mg ยท Comprimido de liberaciรณn prolongada | Potassium | Spain | Marketed | 1993 |
| Adasuve | Loxapine | EU (EMA) | Authorised | 2013 |
| Adasuve 4,5 mg inhalatiepoeder, voorverdeeldInhalatiepoeder, voorverdeeld | Loxapine | Netherlands | Authorised | 2013 |
| Adasuve 9,1 mg inhalatiepoeder, voorverdeeldInhalatiepoeder, voorverdeeld | Loxapine | Netherlands | Authorised | 2013 |
| ADASUVE 9,1 MG POLVO PARA INHALACION (UNIDOSIS)9,1 mg ยท Polvo para inhalaciรณn (unidosis) | Loxapine | Spain | Marketed | 2016 |
| ADASUVE 9,1 MG POLVO PARA INHALACION (UNIDOSIS)9,1 mg ยท Polvo para inhalaciรณn (unidosis) | Loxapine | Spain | Authorised | 2013 |
| ALZIL 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG10,42 mg ยท Comprimido recubierto con pelรญcula | Rosuvastatin | Spain | Marketed | 2017 |
| ALZIL 15 MG COMPRIMIDOS RECUBIERTOS CON PELICULA15,83 mg ยท Comprimido recubierto con pelรญcula | Rosuvastatin | Spain | Marketed | 2023 |
| ALZIL 20 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG20,84 mg ยท Comprimido recubierto con pelรญcula | Rosuvastatin | Spain | Marketed | 2017 |
| ALZIL 30 MG COMPRIMIDOS RECUBIERTOS CON PELICULA31,679 mg ยท Comprimido recubierto con pelรญcula | Rosuvastatin | Spain | Marketed | 2023 |
| ALZIL 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG5,21 mg ยท Comprimido recubierto con pelรญcula | Rosuvastatin | Spain | Marketed | 2017 |
| ALZIL PLUS 10 MG/10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA10,4 mg + 10 mg ยท Comprimido recubierto con pelรญcula | Rosuvastatin, Ezetimiba | Spain | Marketed | 2020 |
| ALZIL PLUS 20 MG/10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA20,8 mg + 10 mg ยท Comprimido recubierto con pelรญcula | Rosuvastatin, Ezetimiba | Spain | Marketed | 2020 |
| ALZIL PLUS 40 MG/10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA41,6 mg + 10 mg ยท Comprimido recubierto con pelรญcula | Rosuvastatin, Ezetimiba | Spain | Marketed | 2020 |
| ALZIL PLUS 5 MG/10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA5,2 mg + 10 mg ยท Comprimido recubierto con pelรญcula | Rosuvastatin, Ezetimiba | Spain | Marketed | 2020 |
| ANGINOVAG SOLUCION PARA PULVERIZACION BUCAL1,0 mg + 0,6 mg + 0,6 mg + 4 mg + 1 mg ยท Soluciรณn para pulverizaciรณn bucal | Decualinio, Enoxolona, Hydrocortisone, Tirotricina, Lidocaine | Spain | Marketed | 1962 |
| CAPTOR 37,5 MG/325 MG COMPRIMIDOS EFG325 mg + 37,5 mg ยท Comprimido | Paracetamol, Tramadol | Spain | Marketed | 2012 |
| CAPTOR 75 mg/650 mg COMPRIMIDOS75 mg + 650 mg ยท Comprimido | Tramadol, Paracetamol | Spain | Marketed | 2012 |
| CAPTOR SIMPLEX 100 MG CAPSULAS DURAS DE LIBERACION PROLONGADA100 mg ยท Cรกpsula dura de liberaciรณn prolongada | Tramadol | Spain | Marketed | 2007 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Spain | 115 | 87 | 28 | CompaniesAll medicines |
| Romania | 8 | 0 | 8 | CompaniesAll medicines |
| Saudi Arabia | 8 | 8 | 0 | CompaniesAll medicines |
| Netherlands | 6 | 6 | 0 | CompaniesAll medicines |
| Croatia | 4 | 4 | 0 | CompaniesAll medicines |
| European Union (EMA) | 3 | 1 | 2 | CompaniesAll medicines |
| Canada | 1 | 1 | 0 | CompaniesAll medicines |
Also in the registers of Brazil, Colombia, France, Italy, Malaysia, Serbia, Singapore, Sweden
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Companies are grouped by Prognia from the names regulators publish; not an official corporate structure.
Source: European Medicines Agency (EPAR data).
Licence: EMA reuse policy (source acknowledgement required)
Fuente de la informaciรณn: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Source: BDPM (ANSM, HAS, UNCAM).
Licence: Licence Ouverte v1.0
ASIC,ASIC - Company Dataset,declared13October2026 extract,CC BY3.0 Australia,https://data.gov.au/data/dataset/asic-companies. Normalized and independently classified by Prognia;no endorsement.
Licence: Creative Commons Attribution 3.0 Australia
Anvisa, https://dados.anvisa.gov.br/dados/CONSULTAS/EMPRESA_FISCALIZACAO_PRODUTO/TA_CONSULTA_CBPF_MEDICAMENTO_DETALHE.CSV; source modified Fri, 15 May 2026 07:52:35 GMT; acquired 2026-10-18T08:23:43.211112+00:00; original factual values retained, no endorsement.
Licence: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions
Anvisa, official medicine/API manufacturer factual export, HTTP source version Fri, 09 Oct 2026 08:21:54 GMT, acquired 2026-10-09; exact unmodified native identifiers and fields preserved.
Licence: Brazil federal factual open-data reuse; Decreto 8777/2016 consolidated article 4 and third-party exceptions
Health Canada, Drug Product Database, company API, entire response observed 2026-10-10T15:12:05.508784+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.
Licence: Open Government Licence Canada
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM otros; source update 2026-09-16; acquired 2026-10-08.
Licence: CC BY-SA 4.0
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vencidos; source update 2026-09-16; acquired 2026-10-08.
Licence: CC BY-SA 4.0
Instituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vigentes; source update 2026-09-16; acquired 2026-10-08.
Licence: CC BY-SA 4.0
Report an error or request removalCorrections from the company itself are welcome.
Keep Ferrerโs medicines accurate on Prognia, see how professionals use them and answer what they ask. A 20-minute call, in English.
Book a callInstituto Nacional de Vigilancia de Medicamentos y Alimentos (INVIMA), Colombia, CUM vigentes, dataset i7cb-raxc, rowsUpdatedAt 1792152574, acquired 2026-10-26; original values retained.
Licence: CC BY-SA 4.0
Fuente de la informaciรณn: Agencia Espaรฑola de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la informaciรณn: Agencia Espaรฑola de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
BDPM / ANSM, HAS and UNCAM; original URLs and each update date retained
Licence: BDPM exact Licence Ouverte v1.0 (October 2011)
BDPM / ANSM, HAS and UNCAM, CIS_MITM.txt, published 13/10/2026, acquired 2026-10-25T22:15:46.803459+00:00; exact facts retained, no endorsement.
Licence: BDPM exact Licence Ouverte v1.0 (October 2011)
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licence: Otvorena dozvola RH
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_H_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:40 GMT; acquired 2026-10-13T17:21:06.034935+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
National Pharmaceutical Regulatory Agency and Ministry of Health Malaysia, KKMNOW Approved Pharmaceutical Products, https://data.moh.gov.my/data-catalogue/pharmaceutical_products; CC BY 4.0; original data as of 2026-09-30 23:59; acquired 2026-10-16T22:34:39.948031+00:00; Prognia preserves original records and projects exact MAL IDs and category/role fields. No government endorsement implied.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0), exact MOH dataset dedication
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Ministerul Sฤnฤtฤศii, Catalogul public naลฃional al preลฃurilor, 18 iunie 2021, downloaded 2026-10-08 from data.gov.ro; CC BY 4.0; structured factual adaptation, code whitespace trimmed only where explicitly recorded.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Licence: Serbian Open Data Licence (sodl)
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licence: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Lรคkemedelsverket, Sweden, Fรถrvaringstemperatur och hรฅllbarhet, source extract 2026-10-20, acquired 2026-10-20T20:46:08.868635+00:00. Original cells retained; structured adaptation by Prognia. No regulator endorsement.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
Lรคkemedelsverket, Sweden, Lรคkemedelsprodukter, source extract 2026-10-20, acquired 2026-10-20T20:45:53.483733+00:00. Original cells retained; structured adaptation by Prognia. No regulator endorsement.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licence: Singapore Open Data Licence
Well-known pharmaceutical groups, each with all its companies.
Ranked by their number of medicines.
